Antifungal Resistance Is Making Thrush Hard To Treat Here's Why

Antifungal Resistance Is Making Thrush Hard To Treat Here's Why. Thrush is one of the most common infections in the world. It ...
NewsBytes

Candida infections are getting harder to treat, says CDC

Scientists warn that Candida, the fungus causing common thrush infections, is rapidly developing resistance to antifungal drugs, complicating treatment options.

Thrush is becoming harder to treat. This is why

Thrush is one of the most common infections in the world. It’s caused by the fungi Candida – specifically, the yeast Candida ...

‘Avoid skin-to-skin contact,’ Brits warned – as ‘super fungus’ that attacks groin and bum ‘spreads at pace’

A ONCE-RARE genital super-fungus that can only be killed off with a ‘toxic’ treatment is now spreading at pace among families ...
FOX 32 Chicago on MSN

Deadly fungal infection Candida auris on the rise in Illinois | ChicagoNOW

Dr. Jatin Vyas explains the dangers, symptoms, and treatment challenges of Candida auris, a highly resistant fungal infection ...

Mycovia Pharmaceuticals, Inc. Announces Publication of 2-Year VIVJOA(R) Efficacy Results from an Extension of the VIOLET Phase 3 Studies in Women with Recurrent Vulvovaginal ...

Mycovia Pharmaceuticals, Inc. ("Mycovia") has announced the publication of long-term efficacy results from an extension study of the VIOLET Phase 3 clinical program which evaluated VIVJOA ...

Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results af…

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.
EurekAlert!

Understanding how the superfungus Candida auris withstands antifungal treatment

A groundbreaking study from Michigan State University (MSU), recently published in Nature Communications, has revealed how the multidrug-resistant superfungus Candida auris uniquely reconstructs its ...